These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2642267)
1. [Experimental studies on pharmacologic protection of the brain against focal ischemia. 2. Effects of KB-2796 and nicardipine on focal brain ischemia in rats]. Shiino A Nihon Geka Hokan; 1989 Sep; 58(5):438-44. PubMed ID: 2642267 [TBL] [Abstract][Full Text] [Related]
2. [Ca++ antagonist and acute brain ischemia: effects of nilvadipine and nicardipine on middle cerebral artery occlusion in rats]. Shiino A; Matsuda M; Handa J; Morikawa S; Kido C; Inubushi T; Susumu T Nihon Geka Hokan; 1991 Jan; 60(1):38-44. PubMed ID: 1819238 [TBL] [Abstract][Full Text] [Related]
3. [Experimental studies on pharmacologic protection of the brain against focal ischemia. 1. Focal brain ischemia model in rats]. Shiino A Nihon Geka Hokan; 1989 Sep; 58(5):431-7. PubMed ID: 2642266 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats. Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345 [TBL] [Abstract][Full Text] [Related]
5. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate. Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234 [TBL] [Abstract][Full Text] [Related]
6. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats. Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449 [TBL] [Abstract][Full Text] [Related]
7. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. Nagayama M; Zhang F; Iadecola C J Cereb Blood Flow Metab; 1998 Oct; 18(10):1107-13. PubMed ID: 9778187 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Yang Y; Li Q; Shuaib A Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates. Furuichi Y; Maeda M; Moriguchi A; Sawamoto T; Kawamura A; Matsuoka N; Mutoh S; Yanagihara T J Cereb Blood Flow Metab; 2003 Oct; 23(10):1183-94. PubMed ID: 14526229 [TBL] [Abstract][Full Text] [Related]
10. Effects of a novel calcium antagonist, KB-2796, on neurologic outcome and size of experimental cerebral infarction in rats. Harada K; Shiino A; Matsuda M; Handa J Surg Neurol; 1989 Jul; 32(1):16-20. PubMed ID: 2734684 [TBL] [Abstract][Full Text] [Related]
11. Effect of allopurinol in focal cerebral ischemia in rats: an experimental study. Işik N; Berkman MZ; Pamir MN; Kalelioğlu M; Sav A Surg Neurol; 2005; 64 Suppl 2():S5-10. PubMed ID: 16256842 [TBL] [Abstract][Full Text] [Related]
12. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage. Iwai M; Chen R; Ide A; Iwanami J; Tomochika H; Tomono Y; Mogi M; Horiuchi M J Hypertens; 2006 Oct; 24(10):2023-31. PubMed ID: 16957563 [TBL] [Abstract][Full Text] [Related]
13. Effect of JTP-2942, a novel thyrotropin-releasing hormone analog, on motor deficits after chronic focal cerebral ischemia in rats. Yonemori F; Yamaguchi T; Nakayama H; Narita K; Hojo S; Tamura A J Cereb Blood Flow Metab; 2000 Jan; 20(1):74-81. PubMed ID: 10616795 [TBL] [Abstract][Full Text] [Related]
14. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. Endres M; Namura S; Shimizu-Sasamata M; Waeber C; Zhang L; Gómez-Isla T; Hyman BT; Moskowitz MA J Cereb Blood Flow Metab; 1998 Mar; 18(3):238-47. PubMed ID: 9498840 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia. Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603 [TBL] [Abstract][Full Text] [Related]
18. Effects of hyperglycemia on ischemic brain damage, local cerebral blood flow and ischemic cerebral edema. Yura S Hokkaido Igaku Zasshi; 1991 Jan; 66(1):1-15. PubMed ID: 2004735 [TBL] [Abstract][Full Text] [Related]
19. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. Morikawa E; Ginsberg MD; Dietrich WD; Duncan RC; Kraydieh S; Globus MY; Busto R J Cereb Blood Flow Metab; 1992 May; 12(3):380-9. PubMed ID: 1569134 [TBL] [Abstract][Full Text] [Related]